Xiangdong Alan Wang

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2002-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiangdong Alan Wang. Retrieved from https://idiyas.com/inventor/xiangdong-alan-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 36.4

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 7.7

ph-index = 8

Forward Citations = 301(Granted Patents)

Company Filing History:

11 out of 3,742

Bristol-Myers Squibb Compnay

patents

Years Active: 2002-2012

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8299094 - Hepatitis C virus inhibitors (2012-10-30),

2. 7915291 - Hepatitis C virus inhibitors (2011-03-29),

3. 7592336 - Hepatitis C virus inhibitors (2009-09-22),

4. 7449479 - Hepatitis C virus inhibitors (2008-11-11),

5. 7135462 - Hepatitis C virus inhibitors (2006-11-14),

6. 6995174 - Hepatitis C virus inhibitors (2006-02-07),

7. 6919331 - Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents (2005-07-19),

8. 6844342 - Heterocyclic substituted 2-methyl-benzimidazole antiviral agents (2005-01-18),

9. 6774134 - Heterocyclic substituted 2-methyl-benzimidazole antiviral agents (2004-08-10),

10. 6506738 - Benzimidazolone antiviral agents (2003-01-14),

11. 6489338 - Imidazopyridine and imidazopyrimidine antiviral agents (2002-12-03),

Title: Innovations and Contributions of Inventor Xiangdong Alan Wang

Introduction

Xiangdong Alan Wang, based in Guilford, CT, is a prominent inventor known for his significant contributions to the field of pharmaceutical research. With a remarkable portfolio of 11 patents, he has made strides particularly in the development of inhibitors for the Hepatitis C virus.

Latest Patents

Among his noteworthy achievements, Xiangdong Alan Wang's latest patents focus on Hepatitis C virus inhibitors. These innovative compounds are disclosed to possess a general formula aimed at combating the Hepatitis C virus, showcasing his dedication to addressing critical health challenges.

Career Highlights

Xiangdong Alan Wang is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has enabled him to drive forward cutting-edge research and development, resulting in impactful innovations within the medical field.

Collaborations

Throughout his career, Xiangdong has collaborated with talented professionals, including Ny Sin and Li-Qiang Sun. These partnerships have been essential in fostering a creative environment that encourages innovation and the successful realization of their research goals.

Conclusion

In summary, Xiangdong Alan Wang stands out as an influential inventor in the pharmaceutical sector, with a focus on Hepatitis C virus inhibitors. His contributions, combined with collaboration and comprehensive research efforts at Bristol-Myers Squibb Company, signify his important role in advancing healthcare solutions. As he continues to innovate, Wang exemplifies the spirit of invention that drives progress within the industry.

Profile summary based on public USPTO records.